PDK1 and acute myeloid leukemia: Targeting PDK1 drives AML cells into an oxygen consumption rate mode resulting in mitochondrial stress-mediated toxicity and PDK1 inhibition sensitizes leukemic cells to GLS inhibitors as a consequence of glutamine-dependent metabolic rewiring.